Meeder Asset Management Inc. Takes Position in HCA Healthcare, Inc. $HCA

Meeder Asset Management Inc. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 2,245 shares of the company’s stock, valued at approximately $875,000.

A number of other large investors have also made changes to their positions in HCA. Nomura Asset Management Co. Ltd. grew its position in shares of HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after purchasing an additional 3,724 shares during the period. Advisors Capital Management LLC boosted its holdings in shares of HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after buying an additional 2,604 shares during the period. Liberty Wealth Management LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $1,905,000. Arrowstreet Capital Limited Partnership boosted its stake in HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after purchasing an additional 245,887 shares during the period. Finally, Sunbelt Securities Inc. raised its stake in shares of HCA Healthcare by 171.7% in the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after purchasing an additional 3,945 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Up 1.8%

NYSE:HCA opened at $412.27 on Wednesday. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The stock’s 50 day moving average price is $395.07 and its two-hundred day moving average price is $445.35. The firm has a market capitalization of $89.26 billion, a price-to-earnings ratio of 13.80, a P/E/G ratio of 1.40 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the prior year, the business earned $6.84 EPS. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities research analysts expect that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 10.45%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on HCA shares. Deutsche Bank Aktiengesellschaft set a $476.00 target price on HCA Healthcare in a research report on Monday, July 27th. UBS Group decreased their target price on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research report on Monday, July 27th. KeyCorp lowered their target price on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a research report on Monday, July 27th. Barclays lowered their price target on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research report on Monday, July 27th. Finally, Truist Financial cut their price objective on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $465.59.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.